Is drug pricing going to become an election issue in 2016?

As many of our readers will be well aware, The “New” Prostate Cancer InfoLink has long argued that, if the biopharmaceutical industry doesn’t take serious steps to manage the problems of increasing prices that come with no real commensurate value, then someone else will take those steps for them. … READ MORE …